Pegylated liposomal tumor necrosis factor‐α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma‐bearing ratsTimo L.M. ten Hagen, Alexander M.M. Eggermont, Ann L.B. Seynhaeve et al.|International Journal of Cancer|2001Cited by 64
Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing ratsA.H. van der Veen, Timo L.M. ten Hagen, Ann L.B. Seynhaeve et al.|International Journal of Cancer|1998Cited by 50
Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusionBoudewijn van Etten, Timo L.M. ten Hagen, Mark R. de Vries et al.|British Journal of Cancer|2003Cited by 48